Please ensure Javascript is enabled for purposes of website accessibility

Why Marijuana Stock OrganiGram Holdings Got Smoked on Tuesday

By Eric Volkman – Jul 21, 2020 at 6:50PM

You’re reading a free article with opinions that may differ from The Motley Fool’s Premium Investing Services. Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn More

Another quarter, another bad showing from a noted cannabis company.

What happened

OrganiGram Holdings (OGI -2.79%) stockholders caught the worst kind of financial buzz on Tuesday, when their shares lost 9.2% in value.

The reason why is clear -- earnings. The marijuana company released its third quarter of fiscal 2020 results, and they hardly made anyone giddy and euphoric.

Wilted marijuana plants.

Image source: Getty Images.

So what

OrganiGram's Q3 net revenue was 18.0 million Canadian dollars ($13.3 million), down sharply from both the CA$24.8 million ($18.3 million) of Q3 2019, and the CA$23.2 million ($17.1 million) of the preceding quarter. The company's net loss was just under CA$90 million ($66.4 million), or CA$0.51 ($0.38) per share. This was more than nine times worse than the year-ago result, and far steeper than Q2's CA$6.8 million ($5.0 million) shortfall.

Even these diminished figures failed to meet analyst expectations. On average, prognosticators were estimating CA$22.4 million ($16.5 million) on the top line, and a per-share net loss of only CA$0.04 ($0.03).

OrganiGram attributed its poor showing to recent job cuts, saying these "contributed to a number of product launch delays, including our initial large format value offering, which affected opportunities to potentially capture significant market share and sales in dried flower, the largest product segment of the recreational market."

Now what

OrganiGram is optimistic about recent new product introductions and extensions to existing lines. Those far-worse-than-expected results are deeply concerning, however, and investor patience has already been stretched thin by the struggling company.

Eric Volkman has no position in any of the stocks mentioned. The Motley Fool owns shares of and recommends OrganiGram Holdings. The Motley Fool has a disclosure policy.

Premium Investing Services

Invest better with The Motley Fool. Get stock recommendations, portfolio guidance, and more from The Motley Fool's premium services.